|Friday, 31st July 2020
1pm - 2.15pm - Eastern Australian Time
3pm - 4.15pm - New Zealand Standard Time
||Complimentary 100 places LESANZ members have priority
Chris Hopkins, Director, SouthMed
Iain Hosie, Technical Director and Founder, Revolution Fibres and
Stephanie Grant, IP Manager, Wellington Univentures
Interested in hearing the challenges and IP implications of medical innovations during a pandemic?
In this webinar we will hear:
- How a desperate need for ventilator supplies during lockdown spurred the creation of a new medical device company
- How the global shortage of face masks saw Revolution Fibres scale up nanofibre production exponentially during lockdown
- About Crown Use provisions – what they are and their implications during pandemics for companies who may be infringing IPR or wanting to protect their IPR in the course of product development
Chris Hopkins, SouthMed, Director
Chris founded SouthMed during lockdown in response to a call for help from NZ Trade Minister David Parker because overseas ventilator supplies were unavailable. Chris assembled a cross-functional team to develop a ventilator hood which could be manufactured in NZ, completing the first prototype during the first four weeks of Level 4 lockdown. Chris is an experienced executive and director delivering growth in Engineering, Robotics and Automation.
Iain Hosie, Revolution Fibres, Technical Director and Founder
Iain is the Co-founder and Technical Director of Revolution Fibres. Iain has been deeply involved in nanofibre production and the development of many unique nanofibre products in the past ten years and has led the business as CEO since 2012, recently moving to the Technical Director role. Iain is a scientist (BSc, Biochemistry) with a background in environmental health, government policy, product development and sales.
Stephanie Grant, Wellington Univentures, IP Manager
Stephanie is a registered trans-Tasman patent attorney with a PhD in
Chemistry. Stephanie’s role is to protect the IP associated with
research discoveries at Victoria University,
Wellington. Prior to UniVentures Stephanie held various roles in
biopharmaceuticals, organic chemistry and as a Patent Executive.